- Home
- BHC vs NAD Comparison
BHC vs NAD Comparison
Compare BHC & NAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHC | NAD |
|---|---|---|
| Founded | N/A | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | BHC | NAD |
|---|---|---|
| Price | $8.26 | $10.88 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.70 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 1.7M |
| Earning Date | 10-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.33 | $9.66 |
| 52 Week High | $9.04 | $12.31 |
Technical Indicators
Market Signals| Indicator | BHC | NAD |
|---|---|---|
| Relative Strength Index (RSI) | 74.93 | 61.80 |
| Support Level | $5.49 | $9.85 |
| Resistance Level | N/A | $11.92 |
| Average True Range (ATR) | 0.37 | 0.17 |
| MACD | 0.24 | 0.09 |
| Stochastic Oscillator | 78.69 | 100.00 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
About NAD Nuveen Quality Municipal Income Fund
Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.